PPC vs. MED, HSY, GIS, K, MKC, TSN, HRL, SJM, CAG, and CPB
Should you be buying Pilgrim's Pride stock or one of its competitors? The main competitors of Pilgrim's Pride include Medifast (MED), Hershey (HSY), General Mills (GIS), Kellanova (K), McCormick & Company, Incorporated (MKC), Tyson Foods (TSN), Hormel Foods (HRL), J. M. Smucker (SJM), Conagra Brands (CAG), and Campbell's (CPB).
Pilgrim's Pride vs. Its Competitors
Medifast (NYSE:MED) and Pilgrim's Pride (NASDAQ:PPC) are both consumer staples companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, analyst recommendations, media sentiment, earnings, dividends and profitability.
95.5% of Medifast shares are held by institutional investors. Comparatively, 16.6% of Pilgrim's Pride shares are held by institutional investors. 2.9% of Medifast shares are held by insiders. Comparatively, 82.6% of Pilgrim's Pride shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Pilgrim's Pride has a net margin of 6.72% compared to Medifast's net margin of -1.29%. Pilgrim's Pride's return on equity of 36.95% beat Medifast's return on equity.
Medifast has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500. Comparatively, Pilgrim's Pride has a beta of 0.45, indicating that its share price is 55% less volatile than the S&P 500.
In the previous week, Pilgrim's Pride had 3 more articles in the media than Medifast. MarketBeat recorded 5 mentions for Pilgrim's Pride and 2 mentions for Medifast. Medifast's average media sentiment score of 1.84 beat Pilgrim's Pride's score of 1.22 indicating that Medifast is being referred to more favorably in the media.
Pilgrim's Pride has higher revenue and earnings than Medifast. Medifast is trading at a lower price-to-earnings ratio than Pilgrim's Pride, indicating that it is currently the more affordable of the two stocks.
Medifast presently has a consensus target price of $16.50, suggesting a potential upside of 13.17%. Pilgrim's Pride has a consensus target price of $48.67, suggesting a potential upside of 6.33%. Given Medifast's higher probable upside, research analysts clearly believe Medifast is more favorable than Pilgrim's Pride.
Summary
Pilgrim's Pride beats Medifast on 12 of the 16 factors compared between the two stocks.
Get Pilgrim's Pride News Delivered to You Automatically
Sign up to receive the latest news and ratings for PPC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding PPC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Pilgrim's Pride Competitors List
Related Companies and Tools
This page (NASDAQ:PPC) was last updated on 7/3/2025 by MarketBeat.com Staff
Free PPC Stock Alerts